More Press Releases

View Older Stories View Newer Stories

Oct 5, 2026 08:00AM Emil Ben-David, CFP®, Joins Prime Capital Financial
Oct 5, 2026 08:00AM Airsys and Shell Showcase Spray Liquid Cooling for Data Centers at OCP Global Summit
Oct 5, 2026 08:00AM Lumentum Announces Reporting Date for Fiscal First Quarter 2027 Financial Results
Oct 5, 2026 08:00AM Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026
Oct 5, 2026 08:00AM Teledyne Surpasses Over One Billion Infrared Pixels Delivered in Support of the Space Development Agency’s Proliferated Warfighter Space Architecture and Begins AMDT3 Golden Dome Production
Oct 5, 2026 08:00AM Cohen & Company Capital Markets Launches Private Credit Advisory Practice
Oct 5, 2026 08:00AM Northern Trust Wealth Management Continues Northeast Region Expansion with Two Senior Appointments
Oct 5, 2026 08:00AM Stellar Cyber 7.0 Makes the Agentic SOC Measurable, Actionable and Operational at Scale
Oct 5, 2026 08:00AM Gallup and The Rippel Foundation Report Finds U.S. Well-Being Rates Near Historic Lows, But Local Communities Are Charting A Path Forward
Oct 5, 2026 08:00AM Holiday Shoppers Turn to Gift Cards as Budgets Tighten
Oct 5, 2026 08:00AM Habitat for Humanity's new global research report finds three in four people are cutting back on essentials to afford housing
Oct 5, 2026 08:00AM Wells Fargo to Announce Third Quarter 2026 Earnings on Oct. 13, 2026
Oct 5, 2026 08:00AM Ryan Establishes Presence in Brazil With Acquisition of Tax Technology Firm Comtax
Oct 5, 2026 08:00AM SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
Oct 5, 2026 08:00AM McGraw Hill to Release Fiscal Second Quarter 2027 Financial Results and Host Webcast on November 5, 2026
Oct 5, 2026 08:00AM Toshiba Accelerates the Human Element in AI Workflows
Oct 5, 2026 08:00AM Hans Vestberg Joins Evercore as Senior Advisor
Oct 5, 2026 08:00AM HOPE Global Forums Announces 2026 Annual Meeting on December 2-3 in Atlanta
Oct 5, 2026 08:00AM Jamie Showers Joins Edgar Matthews & Co. as Managing Director and Head of Syndicate & Sales
Oct 5, 2026 08:00AM I2Pure Expands Leadership and Scientific Team with Three Key Hires in Production, Quality Engineering, and Biomaterials Science
Oct 5, 2026 08:00AM Expand Energy Selects Thoughtworks to Scale AI Across the Enterprise
Oct 5, 2026 08:00AM PLDT Wins Silver Award at 2026 UiPath AI Breakthrough Awards for Agentic AI-Driven Enterprise Transformation
Oct 5, 2026 08:00AM Syntec Optics (Nasdaq: OPTX) Lands Artemis III Production Orders, Expands Space Portfolio to Moon Missions
Oct 5, 2026 08:00AM MindWave Innovations Signs Agreement with US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network
Oct 5, 2026 08:00AM Mastercard Selects Rezolve Ai in Worldwide Reseller Agreement to Advance AI-Powered Commerce
Oct 5, 2026 08:00AM Coveron completes SOC 2 Type II certification with zero exceptions
Oct 5, 2026 08:00AM Osisko Gold Intersects 7.28 g/t Au over 16.15 m (105 m Vertical Depth), including 173.66 g/t Au over 0.60 m, and 7.13 g/t Au over 11.60 m (61 m Vertical Depth) in Lowhee Zone Underground Infill Drilli
Oct 5, 2026 08:00AM Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acr
Oct 5, 2026 08:00AM Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
Oct 5, 2026 08:00AM DFDV Preliminary Q3’26 Estimates Indicate Double-Digit SPS Growth and More Than 100% NAV Per Share Growth In Q3; SOL Treasury Growth Rises to 11% Since August 12
Oct 5, 2026 08:00AM VoltaGrid Completes $775 Million Primary Equity Investment and Upsized $800 Million Secondary Equity Investment
Oct 5, 2026 08:00AM vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
Oct 5, 2026 08:00AM Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
Oct 5, 2026 08:00AM TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement
Oct 5, 2026 08:00AM Kratos Secures More Than $100 Million in Contracts for Space and Cyber Mission Capabilities
Oct 5, 2026 08:00AM Magnite to Announce Third Quarter 2026 Financial Results on November 4, 2026
Oct 5, 2026 08:00AM OnCusp Therapeutics Announces Positive Phase 1b Data Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Resistant Ovarian Cancer (PROC) Presented at Plenary Oral Session of the
Oct 5, 2026 08:00AM Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer
Oct 5, 2026 08:00AM MAPS and International Alliance of Psychedelic Therapy Practitioners Announce Partnership to Advance Training for Psychedelic-Assisted Therapy
Oct 5, 2026 08:00AM Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
Oct 5, 2026 08:00AM Trasteel Holding S.A., Through Newly Established Trasteel Magona, Takes Over Operations of La Magona d’Italia Steel Plant in Piombino, Italy
Oct 5, 2026 08:00AM 4DMT to Host Investor Day on October 21, 2026
Oct 5, 2026 08:00AM Altus Achieves Leading AI Governance Certification, Setting New Standard for Responsible AI in Commercial Real Estate
Oct 5, 2026 08:00AM Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
Oct 5, 2026 08:00AM PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026
Oct 5, 2026 08:00AM Safety in Action® Conference Celebrates 40 Years of Advancing Workplace Safety in 2027
Oct 5, 2026 08:00AM Angeion Group Names Lenny Izzo as Managing Director, Corporate Bankruptcy
Oct 5, 2026 08:00AM BEYYON Rechargeable Hand Warmers with LED Displays: Two Market-Tested Cold-Weather Essentials, Each in a 2-Pack
Oct 5, 2026 08:00AM Inside Information: Preliminary result of Martela Corporation’s directed share issue
Oct 5, 2026 08:00AM Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
View Newer Stories View Older Stories